OpenURL Connection Search

Select item for more details and to access through your institution.

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
Published in:
2020
By:
- Gronchi, Alessandro;
- Bonvalot, Sylvie;
- Poveda Velasco, Andres;
- Kotasek, Dusan;
- Rutkowski, Piotr;
- Hohenberger, Peter;
- Fumagalli, Elena;
- Judson, Ian R.;
- Italiano, Antoine;
- Gelderblom, Hans J.;
- van Coevorden, Frits;
- Penel, Nicolas;
- Kopp, Hans-Georg;
- Duffaud, Florence;
- Goldstein, David;
- Broto, Javier Martin;
- Wardelmann, Eva;
- Marréaud, Sandrine;
- Smithers, Mark;
- Le Cesne, Axel
Publication type:
journal article
Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer.
Published in:
2018
By:
- Zunder, Stéphanie M.;
- van Pelt, Gabi W.;
- Gelderblom, Hans J.;
- Mancao, Christoph;
- Putter, Hein;
- Tollenaar, Rob A.;
- Mesker, Wilma E.
Publication type:
journal article
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Published in:
Oncologist, 2024, v. 29, n. 5, p. 431, doi. 10.1093/oncolo/oyad320
By:
- Spiekman, Ilse A C;
- Geurts, Birgit S;
- Zeverijn, Laurien J;
- Wit, Gijs F de;
- van der Noort, Vincent;
- Roepman, Paul;
- Leng, Wendy W J de;
- Jansen, Anne M L;
- Kusters, Benno;
- Beerepoot, Laurens V;
- Vos, Filip Y F L de;
- Groot, Derk-Jan A de;
- Groot, Jan Willem B de;
- Hoeben, Ann;
- Buter, Jan;
- Gelderblom, Hans A J;
- Voest, Emile E;
- Verheul, Henk M W
Publication type:
Article

Found: 3

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer.

Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.